Ospomyv Injection, Solution
Product Images NDC 83457-012

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ospomyv (NDC 83457-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cordavis Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ospomyv 01)

An instructional illustration of a prefilled syringe for OSPOMYV (denosumab) injection. The diagram labels key syringe components including the needle cap, window, safety guard, finger grip, and plunger, showing the design features for subcutaneous administration.*

FDA Label Image

Image (Ospomyv 02)

An instructional diagram showing a hand holding a pre-filled syringe with the needle cap being removed by another hand pulling it outward. This image visually demonstrates the step of removing the needle cap before subcutaneous injection administration.*

FDA Label Image

Image (Ospomyv 03)

An instructional illustration showing recommended subcutaneous injection sites on the human body. Shaded areas indicate the upper thigh, abdomen, and upper arm as preferred locations for injection administration.*

FDA Label Image

Image (Ospomyv 04)

An instructional illustration showing a hand holding a syringe administering a subcutaneous injection into the forearm of the opposite arm.*

FDA Label Image

Image (Ospomyv 05)

An instructional line drawing showing a hand holding a syringe with the cap being removed from the needle. The syringe appears designed for subcutaneous injection. No text or labeling is visible in the image.*

FDA Label Image

Image (Ospomyv 06)

Instructional illustration showing a hand holding a prefilled syringe of OSPOMYV (denosumab) injection, solution 60 mg/mL. An arrow indicates pulling or removing a cap or cover from the syringe prior to subcutaneous administration.*

FDA Label Image

Figure 1 (Ospomyv 07)

A line graph comparing patient hip fracture incidence (%) over a 36-month study period between two groups: Placebo (dashed line, N=3906) and Denosumab (solid line, N=3902). The x-axis represents study months (0 to 36), and the y-axis shows hip fracture incidence percentage (0 to 10%). The graph depicts a lower incidence trend for the Denosumab group compared to Placebo.*

FDA Label Image

Principal Display Panel (60 mg/mL Syringe Carton)

OSPOMYV 60 mg/mL (denosumab-dssb) injection solution label for a single-dose prefilled syringe, for subcutaneous use only. The label includes the product name, strength, dosage form, route, and instructions for use. It is manufactured by Samsung Bioepis Co., Ltd. and labeled for Cordavis Limited. Additional storage and usage information, barcode, and manufacturer details are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.